•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

AB+942 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A942
 
SPONSOR: Rosenthal L
  TITLE OF BILL: An act to amend the public health law, in relation to authorizing and establishing a training program for paramedics for the administration of buprenorphine   PURPOSE: To authorize emergency medical services workers to administer buprenor- phine to a patient who has suffered an overdose, creating an entryway to treatment.   SUMMARY OF SPECIFIC PROVISIONS: Section one amends section 3309 of the public health law adding a new subdivision 7. Section two amends the public health law by adding a new section 3055 Section three sets forth the effective date.   JUSTIFICATION: In 2017, emergency medical service (EMS) workers reported 15,616 unique naloxone administrations to individuals suffering an opioid overdose, an increase of 50% since 2015. By administering naloxone, EMS workers are able to quickly reverse an opioid overdose and save a person's life. After administering naloxone, EMS workers typically transport an indi- vidual to a hospital for further evaluation. Many people in recovery benefit from medication assisted treatment, including buprenorphine. Buprenorphine is a medication that has been highly successful in treating opioid use disorder as it decreases crav- ings for opioids, blocks their effects, and suppresses painful, debili- tating withdrawal symptoms. The benefits provided by buprenorphine make it easier for patients to start treatment and reduce chances of relapse. Unlike methadone, buprenorphine can be dispensed by a pharmacy for use at-home, which is preferred by many patients. Buprenorphine can be given soon after naloxone is administered for an opioid overdose, a moment when many people with a substance use disorder are most willing to enter treatment. By beginning this medication imme- diately following naloxone, individuals will have less severe withdrawal symptoms and be set on a path to better manage their substance use disorder. In 2019, New Jersey implemented a program to authorize EMS workers to carry and administer buprenorphine to patients who have suffered an opioid overdose. This legislation would create a similar program in New York State, providing training to EMS workers on the benefits of buprenorphine and authorizing them to carry the medication for patients who suffer an overdose and are willing to begin treatment. By starting medication assisted treatment immediately following an overdose, patients will be more likely to continue on a path to recovery.   LEGISLATIVE HISTORY: 2021-22: A.3462 - Referred to Health 2019-20: A.9584 - Referred to Health   FISCAL IMPLICATIONS: To be determined.   EFFECTIVE DATE: 180 days.
Go to top